SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly lower risk of their cancer getting worse than patients treated with brentuximab vedotin, a monoclonal antibody, and AVD (BV-AVD) a year after starting treatment.

Related Keywords

Texas ,United States ,Toronto ,Ontario ,Canada ,California ,Glendora ,Megan Craig ,Sharon Castellino ,Alex Herrera ,Michaell Leblanc ,Angela Punnett ,Hongli Li ,Susank Parsons ,Davidc Hodgson ,Kelly Davison ,Carla Casulo ,Karam Kelly ,Sarahc Rutherford ,Sharonm Castellino ,Sairah Ahmed ,Georgie Garabet ,Bristol Myers Squibb ,Brads Kahl ,Andrewm Evens ,Sonalim Smith ,Jonathan Friedberg ,Johnp Leonard ,Nancyl Bartlett ,Tufts Medical Center ,Division Of Lymphoma ,Department Of Oncology ,National Clinical Trials Network ,Tufts University School Of Medicine ,Statistical Center ,Division Of Hematology Oncology ,Division Of Lymphoma At City Hope ,Department Of Radiation Oncology ,Fred Hutchinson Cancer Center ,Department Of Pathology ,Princess Margaret Cancer Centre ,University Of Rochester ,Mcgill University ,Emory University ,University Health Network ,Wilmot Cancer Institute ,University Of Chicago ,Department Of Pediatric Oncology ,Winship Cancer Institute At Emory University ,Washington University School Of Medicine ,National Cancer Institute ,Children Oncology Group ,University Of Texas Md Anderson Cancer Center ,Blood Disorders Center ,Cancer Therapy Evaluation Program ,Roswell Park Comprehensive Cancer Center ,Cancer Research Network ,Lymphoma Program ,Development Agreement ,Rutgers Cancer Institute Of New Jersey ,National Institutes Of Health ,Research Network ,National Institutes ,Clinical Trials Network ,Oncology Group ,Aflac Cancer ,Winship Cancer Institute ,Cooperative Research ,Rutgers Cancer Institute ,New Jersey ,Sick Children ,Radiation Oncology ,Tufts University School ,Cancer Center ,Washington University School ,Pediatric Oncology ,Roswell Park Comprehensive Cancer ,Cancer ,Research ,Adolescents ,Ntibody ,Flood ,Brentuximab Vedotin ,Chemotherapy ,Children ,Clinical Trial ,It ,Healthcare ,Hodgkin Lymphoma ,Hospital ,Lymphoma ,Medicine ,Monoclonal Antibody ,Ncology ,Pd L1 ,Protein ,